We have located links that may give you full text access.
Different surface modifications combined with universal adhesives: the impact on the bonding properties of zirconia to composite resin cement.
Clinical Oral Investigations 2019 November
OBJECTIVE: The purpose of this study was to analyze the impact of plasma treatment and (universal adhesives) UAs on the bonding properties of zirconia.
MATERIAL AND METHODS: Zirconia specimens (N = 744; n = 186/pretreatment) were prepared, highly polished, and pretreated: (i) plasma (oxygen plasma, 10s, 5 mm), (ii) airborne-particle abrasion (alumina, 50 μm, 0.05 MPa, 5 s, 10 mm), (iii) airborne-particle abrasion + plasma, and (iv) without pretreatment (highly polished surface). Surface roughness (Ra ) and surface free energy (SFE) were measured (n = 6/pretreatment). Tensile bond strength (TBS) specimens (n = 180/pretreatment) were further divided (n = 18/conditioning): Clearfil Ceramic Primer (PCG), All-Bond Universal (ABU), Adhese Universal (AU), Clearfil Universal Bond (CUB), G-Premio Bond (GPB), Futurabond U (FBU), iBond Universal (IBU), One Coat 7 Universal (OCU), Scotchbond Universal (SBU), and no conditioning. PCG was luted with Panavia F2.0 and the remaining groups with DuoCem. After storage in distilled water (24 h; 37 °C) and thermocycling (5000×; 5 °C/55 °C), TBS was measured and fracture types (FTs) were determined. Data were analyzed using univariate ANOVA with a partial eta square (ƞP 2 ), the Kruskal-Wallis H, the Mann-Whitney U, and the Chi2 test (P < .05).
RESULTS: Plasma treatment resulted in an increase of SFE but had no impact on Ra . Airborne-particle abrasion resulted in the highest Ra and a higher TBS when compared with plasma and non-treatment. SBU and AU obtained a higher TBS when compared with PCG. OCU, FBU, ABU, IBU, and GPB indicated comparable TBS to PCG. CUB revealed the lowest TBS.
CONCLUSIONS: Plasma treatment cannot substitute airborne-particle abrasion when bonding zirconia but MDP-containing adhesives are essential for successful clinical outcomes.
CLINICAL RELEVANCE: Airborne-particle abrasion with a low pressure (0.05 MPa) in combination with UAs promotes the clinical success of adhesively bonded zirconia restorations.
MATERIAL AND METHODS: Zirconia specimens (N = 744; n = 186/pretreatment) were prepared, highly polished, and pretreated: (i) plasma (oxygen plasma, 10s, 5 mm), (ii) airborne-particle abrasion (alumina, 50 μm, 0.05 MPa, 5 s, 10 mm), (iii) airborne-particle abrasion + plasma, and (iv) without pretreatment (highly polished surface). Surface roughness (Ra ) and surface free energy (SFE) were measured (n = 6/pretreatment). Tensile bond strength (TBS) specimens (n = 180/pretreatment) were further divided (n = 18/conditioning): Clearfil Ceramic Primer (PCG), All-Bond Universal (ABU), Adhese Universal (AU), Clearfil Universal Bond (CUB), G-Premio Bond (GPB), Futurabond U (FBU), iBond Universal (IBU), One Coat 7 Universal (OCU), Scotchbond Universal (SBU), and no conditioning. PCG was luted with Panavia F2.0 and the remaining groups with DuoCem. After storage in distilled water (24 h; 37 °C) and thermocycling (5000×; 5 °C/55 °C), TBS was measured and fracture types (FTs) were determined. Data were analyzed using univariate ANOVA with a partial eta square (ƞP 2 ), the Kruskal-Wallis H, the Mann-Whitney U, and the Chi2 test (P < .05).
RESULTS: Plasma treatment resulted in an increase of SFE but had no impact on Ra . Airborne-particle abrasion resulted in the highest Ra and a higher TBS when compared with plasma and non-treatment. SBU and AU obtained a higher TBS when compared with PCG. OCU, FBU, ABU, IBU, and GPB indicated comparable TBS to PCG. CUB revealed the lowest TBS.
CONCLUSIONS: Plasma treatment cannot substitute airborne-particle abrasion when bonding zirconia but MDP-containing adhesives are essential for successful clinical outcomes.
CLINICAL RELEVANCE: Airborne-particle abrasion with a low pressure (0.05 MPa) in combination with UAs promotes the clinical success of adhesively bonded zirconia restorations.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app